BrainCheck: 150 practices joined in 2025 as AI cognitive care workflows scale nationwide — $13M raised to expand
Summary
BrainCheck announced that 150 practices joined its AI-enabled cognitive assessment platform in 2025, demonstrating rapid commercial scaling of digital cognitive care workflows across primary care, neurology, and senior care settings. The company simultaneously raised $13M in additional financing to support nationwide expansion. BrainCheck's platform uses validated cognitive tests on tablets to detect cognitive decline earlier than traditional paper screening, with AI-driven clinical decision support helping primary care physicians manage cognitive health without specialist referral for every patient.
Why it matters
One hundred and fifty new clinical practices adopting an AI cognitive care platform in a single year is the fastest commercial adoption rate for a digital neurology diagnostic tool ever reported. The primary care penetration strategy — bringing cognitive assessment to the physicians who see patients first, rather than waiting for specialist referral — addresses the fundamental bottleneck in early Alzheimer's and dementia detection. With lecanemab and donanemab now requiring pre-treatment amyloid confirmation, demand for scalable cognitive screening infrastructure is at an all-time high.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial